Analysts at Wedbush decreased their Q1 2025 earnings estimates for Wingstop in a research note issued to investors on ...

Long-time Tesla bull Dan Ives, an analyst at Wedbush Securities, says Elon Musk is the only one who can turn the EV maker's ...

Fintel reports that on March 20, 2025, Wedbush initiated coverage of Zenas BioPharma (NasdaqGS:ZBIO) with a Outperform ...

Avalo Therapeutics (NASDAQ:AVTX – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a report ...

Wedbush analyst Dan Ives previously warned Tesla was spiraling into a "brand crisis tornado" amid widespread protests and a ...

Nvidia Corp. (NVDA) stock will be in focus on Wednesday after analysts at Wedbush expressed a bullish outlook for the company ...

Wedbush analyst Robert Driscoll maintained a Buy rating on Monte Rosa Therapeutics (GLUE – Research Report) today and set a price target of ...

Wedbush lowered the firm’s price target on Williams-Sonoma (WSM) to $170 from $190 and keeps a Neutral rating on the shares. The firm notes the ...

Dan Ives, a Wedbush analyst who has been bullish on Tesla, called the automaker's latest woes a "crisis" that only one person ...

Jazmin Gabriela Carpenter, vice president of investments at Wedbush Securities, focuses on developing tailored investment ...

Wedbush’s Dan Ives says CEO Elon Musk faces a “moment of truth,” and there two major things he has to do to fix the “crisis’ ...

I loudly urge Musk and the Board to step up, stop being silent, and help resolve this crisis forming at Tesla,” wrote Wedbush ...